NCT07003867

Brief Summary

Neurological dysfunction is a common condition necessitating prolonged mechanical ventilation (PMV). Among patients with acute neurological diseases, 17% to 33% are intubated and mechanically ventilated for respiratory failure. Patients with acute neurological diseases requiring MV generally have adverse outcomes with a hospital mortality rate among patients with such diseases has been reported to be in the range of 16-33%. Inspiratory muscle weakness is common in patients receiving mechanical ventilation, especially patients with prolonged duration of mechanical ventilation. Inspiratory muscle training could limit or reverse these unhelpful squeal and facilitate more rapid and successful weaning.Hence, the importance of physical therapy emerged in helping patients to be weaned from ventilators by using various methods to strengthen the respiratory muscles in different ways.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 4, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

June 10, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

November 19, 2025

Status Verified

November 1, 2025

Enrollment Period

2 months

First QC Date

May 23, 2025

Last Update Submit

November 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pulmonary compliance ( mL/cmH2O )

    A measure of the lung expandability, which is important in ideal respiratory system function. It refers to the ability of the lungs to stretch and expand. Lung compliance can be calculated by dividing volume by pressure (C = V/P), Pulmonary compliance was assessed daily in all mechanically ventilated patients using data obtained directly from the ventilator system (CARESCAPE -R860/USA)

    pre and post 1 week

Secondary Outcomes (4)

  • Paco2 (mmHg)

    pre and post 1 week of intervention

  • PaO2 ( mmHg )

    pre and post 1 week of intervention

  • HCO3 ( mEq/L )

    Pre and post 1 week of intervention

  • pH

    Pre and post 1 week of intervention

Study Arms (2)

Control group ( threshold inspiratory muscle training )

ACTIVE COMPARATOR
Other: Ventilator inspiratory trigger sensitivity adjustment , threshold device training

Experimental group ( Adjustment of ventilator trigger sensitivity )

EXPERIMENTAL
Other: Ventilator inspiratory trigger sensitivity adjustment , threshold device training

Interventions

Ventilator inspiratory trigger sensitivity adjustment threshold device training

Control group ( threshold inspiratory muscle training )Experimental group ( Adjustment of ventilator trigger sensitivity )

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged 40-60 years.
  • Diagnosed with acute stroke patients.
  • Body mass index (BMI) 18:35 kg/m².
  • conscious oriented patients with Glasgow coma score ≥ 13.
  • PH\>7.25 and arterial oxygen saturation \>90%

You may not qualify if:

  • Persistent hemodynamic instability as life threatening arrhythmias, acute heart failure, angina.
  • Severe breathlessness when spontaneously breathing.
  • Any progressive neuromuscular disease that would interfere with responding to inspiratory muscle training.
  • Spinal cord injuries.
  • Skeletal pathology (scoliosis, flail chest, spinal instrumentation) that would seriously impair the movement of the chest wall and ribs.
  • Patients on heavy sedation and respiratory muscle paralysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohamed Saied Zidan

Cairo, 11571, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant prof dr

Study Record Dates

First Submitted

May 23, 2025

First Posted

June 4, 2025

Study Start

June 10, 2025

Primary Completion

August 15, 2025

Study Completion

September 15, 2025

Last Updated

November 19, 2025

Record last verified: 2025-11

Locations